BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37774796)

  • 1. Real-life use of ceftobiprole for severe infections in a French intensive care unit.
    Bellut H; Arrayago M; Amara M; Roujansky A; Micaelo M; Bruneel F; Bedos JP
    Infect Dis Now; 2024 Feb; 54(1):104790. PubMed ID: 37774796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa.
    Fernandez J; Hilliard JJ; Abbanat D; Zhang W; Melton JL; Santoro CM; Flamm RK; Bush K
    Antimicrob Agents Chemother; 2010 Jan; 54(1):116-25. PubMed ID: 19884364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
    Yoo R; So H; Seo E; Kim M; Lee J
    PLoS One; 2021; 16(4):e0247714. PubMed ID: 33793589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ceftobiprole in a murine model of bacteremia and disseminated infection.
    Cumper C; Richards C; Smart J; Litherland K; Jones M
    J Med Microbiol; 2023 Oct; 72(10):. PubMed ID: 37791651
    [No Abstract]   [Full Text] [Related]  

  • 6. The antimicrobial activity of ceftobiprole against Methicillin-resistant
    Altamimi LA; Altamimi LA; Somily AM
    Saudi Med J; 2022 Jan; 43(1):31-36. PubMed ID: 35022281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA.
    Horn KS; Danziger LH; Rodvold KA; Glowacki RC
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):463-472. PubMed ID: 28264613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.
    Lin JC; Aung G; Thomas A; Jahng M; Johns S; Fierer J
    J Infect Chemother; 2013 Feb; 19(1):42-9. PubMed ID: 22797874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between single trough-based area under the curve estimation of vancomycin and treatment outcome among methicillin-resistant Staphylococcus aureus bacteremia patients.
    Makmor-Bakry M; Ahmat A; Shamsuddin A; Lau CL; Ramli R
    Anaesthesiol Intensive Ther; 2019; 51(3):218-223. PubMed ID: 31434472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ceftaroline and ceftobiprole against methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin isolated in paediatric patients.
    Carnesecchi G; Lobello R; Liggieri L; Palmero C; Pescetto L; Morelli P; Castagnola E; Bandettini R
    J Chemother; 2018; 30(6-8):338-341. PubMed ID: 30375268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
    Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates.
    Antonelli A; Giani T; Coppi M; Di Pilato V; Arena F; Colavecchio OL; Conte V; Santerre Henriksen A; Rossolini GM;
    J Antimicrob Chemother; 2019 Dec; 74(12):3453-3461. PubMed ID: 31652323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Methicillin-Resistant Staphylococcus aureus Nasal Screens to Rule Out Methicillin-Resistant S aureus Pneumonia in Surgical Intensive Care Units.
    Srinivas S; Murphy CV; Bergus KC; Jones WL; Tedeschi C; Tracy BM
    J Surg Res; 2023 Dec; 292():317-323. PubMed ID: 37688946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
    Farrell DJ; Flamm RK; Sader HS; Jones RN
    Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018.
    Flamm RK; Duncan LR; Hamed KA; Smart JI; Mendes RE; Pfaller MA
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
    Prybylski JP
    Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of ceftobiprole, a novel beta-lactam antibiotic.
    Noel GJ
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():25-9. PubMed ID: 17488373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.
    Mendes RE; Deshpande LM; Costello AJ; Farrell DJ; Jones RN; Flamm RK
    Microb Drug Resist; 2016 Jan; 22(1):53-8. PubMed ID: 26230870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.